Cargando…
The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767661/ https://www.ncbi.nlm.nih.gov/pubmed/33300315 http://dx.doi.org/10.3802/jgo.2021.32.e20 |
_version_ | 1783629008519299072 |
---|---|
author | Coleman, Robert L. |
author_facet | Coleman, Robert L. |
author_sort | Coleman, Robert L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7767661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-77676612021-01-05 The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us? Coleman, Robert L. J Gynecol Oncol Expert Opinion Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020-12-02 /pmc/articles/PMC7767661/ /pubmed/33300315 http://dx.doi.org/10.3802/jgo.2021.32.e20 Text en Copyright © 2021. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Expert Opinion Coleman, Robert L. The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us? |
title | The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us? |
title_full | The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us? |
title_fullStr | The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us? |
title_full_unstemmed | The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us? |
title_short | The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us? |
title_sort | role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us? |
topic | Expert Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767661/ https://www.ncbi.nlm.nih.gov/pubmed/33300315 http://dx.doi.org/10.3802/jgo.2021.32.e20 |
work_keys_str_mv | AT colemanrobertl theroleofsecondarycytoreductioninrecurrentplatinumsensitiveovariancancerwhatdothetrialstellus AT colemanrobertl roleofsecondarycytoreductioninrecurrentplatinumsensitiveovariancancerwhatdothetrialstellus |